Alternatives to BloodFlow

AI-powered care coordination platform for faster diagnosis and treatment of critical conditions.

AI-powered breast cancer detection and risk assessment solutions.

Global life sciences company providing diagnostic and biopharma laboratory services.

Wearable devices and AI for continuous health monitoring and early disease detection.

Lunit is a medical AI company developing AI-powered solutions for cancer diagnostics and therapeutics.

Data-driven software solutions for precision medicine and pharmaceutical development.

Specialized services for pharmaceutical and life sciences clients across product development and commercialization.

Leveraging the adaptive immune system to diagnose and treat disease.

R&D cloud platform for life sciences, enabling scientific innovation and productivity.

AI-powered spatial biology platform for precision medicine and drug development.

Natera is a global leader in cell-free DNA testing, providing genetic testing services for reproductive health, oncology, and organ transplantation.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Genomic data analysis platform for rare diseases and cancer.

Fountain Life offers proactive, preventative healthcare and longevity solutions through advanced diagnostics and personalized wellness plans.

AI-powered platform for personalized cell therapy development and manufacturing.

Bonsai automates complex healthcare workflows-helping practices improve patient outcomes, reduce staff workload, and drive sustainable growth.

AI-powered cancer detection and therapy solutions for early diagnosis and personalized risk assessment.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

Digital pathology imaging technology and AI-driven precision pathology software.

BioCorteX is a tech bio company developing precision medicine solutions using AI-powered in-silico simulations to understand drug-bacteria interactions and personalize treatments.